866-997-4948(US-Canada Toll Free)

Global Drugs for Non-small Cell Lung Cancer Market Professional Survey Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Cancer

No. of Pages : 121 Pages

This report studies Drugs for Non-small Cell Lung Cancer in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Sanofi
ZIOPHARM Oncology
Alchemia
Amgen
Apotex
BioMarin Pharmaceutical
CellAct Pharma
Cerulean Pharma
Cipla
Cornerstone Pharmaceuticals
Curis
CytRx
Eli Lilly
Exelixis
Fresenius Kabi
Genentech
Hikma Pharmaceuticals
Hospira
Intas Pharmaceuticals
Karyopharm Therapeutics
Kyowa Hakko Kirin
Ligand Pharmaceuticals

By types, the market can be split into
Surgery
Radiofrequency ablation (RFA)
Radiation therapy
Chemotherapy
Targeted therapies
Immunotherapy

By Application, the market can be split into
Application 1
Application 2
Application 3

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

Table of Contents

1 Industry Overview of Drugs for Non-small Cell Lung Cancer
1.1 Definition and Specifications of Drugs for Non-small Cell Lung Cancer
1.1.1 Definition of Drugs for Non-small Cell Lung Cancer
1.1.2 Specifications of Drugs for Non-small Cell Lung Cancer
1.2 Classification of Drugs for Non-small Cell Lung Cancer
1.2.1 Surgery
1.2.2 Radiofrequency ablation (RFA)
1.2.3 Radiation therapy
1.2.4 Chemotherapy
1.2.5 Targeted therapies
1.2.6 Immunotherapy
1.3 Applications of Drugs for Non-small Cell Lung Cancer
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Drugs for Non-small Cell Lung Cancer
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Drugs for Non-small Cell Lung Cancer
2.3 Manufacturing Process Analysis of Drugs for Non-small Cell Lung Cancer
2.4 Industry Chain Structure of Drugs for Non-small Cell Lung Cancer

3 Technical Data and Manufacturing Plants Analysis of Drugs for Non-small Cell Lung Cancer
3.1 Capacity and Commercial Production Date of Global Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015

4 Global Drugs for Non-small Cell Lung Cancer Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global Drugs for Non-small Cell Lung Cancer Capacity and Growth Rate Analysis
4.2.2 2015 Drugs for Non-small Cell Lung Cancer Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global Drugs for Non-small Cell Lung Cancer Sales and Growth Rate Analysis
4.3.2 2015 Drugs for Non-small Cell Lung Cancer Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global Drugs for Non-small Cell Lung Cancer Sales Price
4.4.2 2015 Drugs for Non-small Cell Lung Cancer Sales Price Analysis (Company Segment)

5 Drugs for Non-small Cell Lung Cancer Regional Market Analysis
5.1 North America Drugs for Non-small Cell Lung Cancer Market Analysis
5.1.1  North America Drugs for Non-small Cell Lung Cancer  Market Overview
5.1.2  North America 2011-2016E Drugs for Non-small Cell Lung Cancer Local Supply, Import, Export, Local Consumption Analysis
5.1.3  North America 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price Analysis
5.1.4  North America 2015 Drugs for Non-small Cell Lung Cancer Market Share Analysis
5.2 China Drugs for Non-small Cell Lung Cancer Market Analysis
5.2.1  China Drugs for Non-small Cell Lung Cancer  Market Overview
5.2.2  China 2011-2016E Drugs for Non-small Cell Lung Cancer Local Supply, Import, Export, Local Consumption Analysis
5.2.3  China 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price Analysis
5.2.4  China 2015 Drugs for Non-small Cell Lung Cancer Market Share Analysis
5.3 Europe Drugs for Non-small Cell Lung Cancer Market Analysis
5.3.1  Europe Drugs for Non-small Cell Lung Cancer  Market Overview
5.3.2  Europe 2011-2016E Drugs for Non-small Cell Lung Cancer Local Supply, Import, Export, Local Consumption Analysis
5.3.3  Europe 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price Analysis
5.3.4  Europe 2015 Drugs for Non-small Cell Lung Cancer Market Share Analysis
5.4 Southeast Asia Drugs for Non-small Cell Lung Cancer Market Analysis
5.4.1  Southeast Asia Drugs for Non-small Cell Lung Cancer  Market Overview
5.4.2  Southeast Asia 2011-2016E Drugs for Non-small Cell Lung Cancer Local Supply, Import, Export, Local Consumption Analysis
5.4.3  Southeast Asia 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price Analysis
5.4.4  Southeast Asia 2015 Drugs for Non-small Cell Lung Cancer Market Share Analysis
5.5 Japan Drugs for Non-small Cell Lung Cancer Market Analysis
5.5.1  Japan Drugs for Non-small Cell Lung Cancer  Market Overview
5.5.2  Japan 2011-2016E Drugs for Non-small Cell Lung Cancer Local Supply, Import, Export, Local Consumption Analysis
5.5.3  Japan 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price Analysis
5.5.4  Japan 2015 Drugs for Non-small Cell Lung Cancer Market Share Analysis
5.6 India Drugs for Non-small Cell Lung Cancer Market Analysis
5.6.1  India Drugs for Non-small Cell Lung Cancer  Market Overview
5.6.2  India 2011-2016E Drugs for Non-small Cell Lung Cancer Local Supply, Import, Export, Local Consumption Analysis
5.6.3  India 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price Analysis
5.6.4  India 2015 Drugs for Non-small Cell Lung Cancer Market Share Analysis

6 Global 2011-2016E Drugs for Non-small Cell Lung Cancer Segment Market Analysis (by Type)
6.1 Global 2011-2016E Drugs for Non-small Cell Lung Cancer Sales by Type
6.2 Different Types of Drugs for Non-small Cell Lung Cancer Product Interview Price Analysis
6.3 Different Types of Drugs for Non-small Cell Lung Cancer Product Driving Factors Analysis
6.3.1 Surgery of Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis
6.3.2 Radiofrequency ablation (RFA) of Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis
6.3.3 Radiation therapy of Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis
6.3.4 Chemotherapy of Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis
6.3.5 Targeted therapies of Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis
6.3.6 Immunotherapy of Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis

7 Global 2011-2016E Drugs for Non-small Cell Lung Cancer Segment Market Analysis (by Application)
7.1 Global 2011-2016E Drugs for Non-small Cell Lung Cancer Consumption by Application
7.2 Different Application of Drugs for Non-small Cell Lung Cancer Product Interview Price Analysis
7.3 Different Application of Drugs for Non-small Cell Lung Cancer Product Driving Factors Analysis
7.3.1 Application 1 Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis
7.3.2 Application 2 Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis
7.3.3 Application 3 Drugs for Non-small Cell Lung Cancer Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Drugs for Non-small Cell Lung Cancer
8.1 Bristol-Myers Squibb
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Bristol-Myers Squibb 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Bristol-Myers Squibb 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.2 GlaxoSmithKline
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 GlaxoSmithKline 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 GlaxoSmithKline 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.3 Menarini
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Menarini 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Menarini 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.4 Sanofi
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Sanofi 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Sanofi 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.5 ZIOPHARM Oncology
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 ZIOPHARM Oncology 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 ZIOPHARM Oncology 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.6 Alchemia
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Alchemia 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Alchemia 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.7 Amgen
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Amgen 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amgen 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.8 Apotex
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Apotex 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Apotex 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.9 BioMarin Pharmaceutical
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 BioMarin Pharmaceutical 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 BioMarin Pharmaceutical 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.10 CellAct Pharma
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 CellAct Pharma 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 CellAct Pharma 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.11 Cerulean Pharma
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Cerulean Pharma 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Cerulean Pharma 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.12 Cipla
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Cipla 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Cipla 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.13 Cornerstone Pharmaceuticals
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.2.1 Type I
8.13.2.2 Type II
8.13.2.3 Type III
8.13.3 Cornerstone Pharmaceuticals 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Cornerstone Pharmaceuticals 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.14 Curis
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.2.1 Type I
8.14.2.2 Type II
8.14.2.3 Type III
8.14.3 Curis 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Curis 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.15 CytRx
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.2.1 Type I
8.15.2.2 Type II
8.15.2.3 Type III
8.15.3 CytRx 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 CytRx 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.16 Eli Lilly
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.2.1 Type I
8.16.2.2 Type II
8.16.2.3 Type III
8.16.3 Eli Lilly 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Eli Lilly 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.17 Exelixis
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.2.1 Type I
8.17.2.2 Type II
8.17.2.3 Type III
8.17.3 Exelixis 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Exelixis 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.18 Fresenius Kabi
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.2.1 Type I
8.18.2.2 Type II
8.18.2.3 Type III
8.18.3 Fresenius Kabi 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Fresenius Kabi 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.19 Genentech
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.2.1 Type I
8.19.2.2 Type II
8.19.2.3 Type III
8.19.3 Genentech 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Genentech 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.20 Hikma Pharmaceuticals
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.2.1 Type I
8.20.2.2 Type II
8.20.2.3 Type III
8.20.3 Hikma Pharmaceuticals 2015 Drugs for Non-small Cell Lung Cancer Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Hikma Pharmaceuticals 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution Analysis
8.21 Hospira
8.22 Intas Pharmaceuticals
8.23 Karyopharm Therapeutics
8.24 Kyowa Hakko Kirin
8.25 Ligand Pharmaceuticals

9 Development Trend of Analysis of Drugs for Non-small Cell Lung Cancer Market
9.1 Global Drugs for Non-small Cell Lung Cancer Market Trend Analysis
9.1.1 Global 2016-2021 Drugs for Non-small Cell Lung Cancer Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Drugs for Non-small Cell Lung Cancer Sales Price Forecast
9.2 Drugs for Non-small Cell Lung Cancer Regional Market Trend
9.2.1 North America 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Forecast
9.2.2 China 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Forecast
9.2.3 Europe 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Forecast
9.2.4 Southeast Asia 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Forecast
9.2.5 Japan 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Forecast
9.2.6 India 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Forecast
9.3 Drugs for Non-small Cell Lung Cancer Market Trend (Product Type)
9.4 Drugs for Non-small Cell Lung Cancer Market Trend (Application)

10 Drugs for Non-small Cell Lung Cancer Marketing Type Analysis
10.1 Drugs for Non-small Cell Lung Cancer Regional Marketing Type Analysis
10.2 Drugs for Non-small Cell Lung Cancer International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Drugs for Non-small Cell Lung Cancer by Regions
10.4 Drugs for Non-small Cell Lung Cancer Supply Chain Analysis

11 Consumers Analysis of Drugs for Non-small Cell Lung Cancer
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Drugs for Non-small Cell Lung Cancer Market Professional Survey Report 2016
Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List of Table

Figure Picture of Drugs for Non-small Cell Lung Cancer
Table Product Specifications of Drugs for Non-small Cell Lung Cancer
Table Classification of Drugs for Non-small Cell Lung Cancer
Figure Global Production Market Share of Drugs for Non-small Cell Lung Cancer by Type in 2015
Figure Surgery Picture
Table Major Manufacturers of  Surgery
Figure Radiofrequency ablation (RFA) Picture
Table Major Manufacturers of  Radiofrequency ablation (RFA)
Figure Radiation therapy Picture
Table Major Manufacturers of  Radiation therapy
Figure Chemotherapy Picture
Table Major Manufacturers of  Chemotherapy
Figure Targeted therapies Picture
Table Major Manufacturers of  Targeted therapies
Figure Immunotherapy Picture
Table Major Manufacturers of  Immunotherapy
Table Applications of Drugs for Non-small Cell Lung Cancer
Figure Global Consumption Volume Market Share of Drugs for Non-small Cell Lung Cancer by Application in 2015
Figure Market Share of Drugs for Non-small Cell Lung Cancer by Regions
Figure North America Drugs for Non-small Cell Lung Cancer Market Size (2011-2021)
Figure China Drugs for Non-small Cell Lung Cancer Market Size (2011-2021)
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size (2011-2021)
Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (2011-2021)
Figure Japan Drugs for Non-small Cell Lung Cancer Market Size (2011-2021)
Figure India Drugs for Non-small Cell Lung Cancer Market Size (2011-2021)
Table Drugs for Non-small Cell Lung Cancer Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Drugs for Non-small Cell Lung Cancer in 2015
Figure Manufacturing Process Analysis of Drugs for Non-small Cell Lung Cancer
Figure Industry Chain Structure of Drugs for Non-small Cell Lung Cancer
Table Capacity (K Units) and Commercial Production Date of Global Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Drugs for Non-small Cell Lung Cancer Major Manufacturers in 2015
Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Drugs for Non-small Cell Lung Cancer 2011-2016
Figure Global 2011-2016E Drugs for Non-small Cell Lung Cancer Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Drugs for Non-small Cell Lung Cancer Market Size (Value) and Growth Rate
Table 2011-2016E Global Drugs for Non-small Cell Lung Cancer Capacity and Growth Rate
Table 2015 Global Drugs for Non-small Cell Lung Cancer Capacity List (Company Segment)
Table 2011-2016E Global Drugs for Non-small Cell Lung Cancer Sales and Growth Rate
Table 2015 Global Drugs for Non-small Cell Lung Cancer Sales List (Company Segment)
Table 2011-2016E Global Drugs for Non-small Cell Lung Cancer Sales Price
Table 2015 Global Drugs for Non-small Cell Lung Cancer Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Drugs for Non-small Cell Lung Cancer 2011-2016 (K Units)
Figure North America 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price (USD/Unit)
Figure North America 2015 Drugs for Non-small Cell Lung Cancer Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Drugs for Non-small Cell Lung Cancer 2011-2016 (K Units)
Figure China 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price (USD/Unit)
Figure China 2015 Drugs for Non-small Cell Lung Cancer Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Drugs for Non-small Cell Lung Cancer 2011-2016 (K Units)
Figure Europe 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price (USD/Unit)
Figure Europe 2015 Drugs for Non-small Cell Lung Cancer Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Drugs for Non-small Cell Lung Cancer 2011-2016 (K Units)
Figure Southeast Asia 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price (USD/Unit)
Figure Southeast Asia 2015 Drugs for Non-small Cell Lung Cancer Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Drugs for Non-small Cell Lung Cancer 2011-2016 (K Units)
Figure Japan 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price (USD/Unit)
Figure Japan 2015 Drugs for Non-small Cell Lung Cancer Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Drugs for Non-small Cell Lung Cancer 2011-2016 (K Units)
Figure India 2011-2016E Drugs for Non-small Cell Lung Cancer Sales Price (USD/Unit)
Figure India 2015 Drugs for Non-small Cell Lung Cancer Sales Market Share
Table Global 2011-2016E Drugs for Non-small Cell Lung Cancer Sales by Type
Table Different Types Drugs for Non-small Cell Lung Cancer Product Interview Price
Table Global 2011-2016E Drugs for Non-small Cell Lung Cancer Sales by Application
Table Different Application Drugs for Non-small Cell Lung Cancer Product Interview Price
Table Bristol-Myers Squibb Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Bristol-Myers Squibb Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Bristol-Myers Squibb 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table GlaxoSmithKline Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 GlaxoSmithKline Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 GlaxoSmithKline 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Menarini Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Menarini Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Menarini 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Sanofi Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Sanofi Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table ZIOPHARM Oncology Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 ZIOPHARM Oncology Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 ZIOPHARM Oncology 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Alchemia Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Alchemia Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Alchemia 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Amgen Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Amgen Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Amgen 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Apotex Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Apotex Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Apotex 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table BioMarin Pharmaceutical Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 BioMarin Pharmaceutical Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 BioMarin Pharmaceutical 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table CellAct Pharma Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 CellAct Pharma Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 CellAct Pharma 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Cerulean Pharma Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Cerulean Pharma Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Cerulean Pharma 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Cipla Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Cipla Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Cipla 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Cornerstone Pharmaceuticals Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Cornerstone Pharmaceuticals Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Cornerstone Pharmaceuticals 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Curis Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Curis Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Curis 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table CytRx Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 CytRx Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 CytRx 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Eli Lilly Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Eli Lilly Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Eli Lilly 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Exelixis Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Exelixis Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Exelixis 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Fresenius Kabi Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Fresenius Kabi Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Fresenius Kabi 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Genentech Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Genentech Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Genentech 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Hikma Pharmaceuticals Information List
Table Type I Drugs for Non-small Cell Lung Cancer Overview
Table Type II Drugs for Non-small Cell Lung Cancer Overview
Table Type III Drugs for Non-small Cell Lung Cancer Overview
Table 2015 Hikma Pharmaceuticals Drugs for Non-small Cell Lung Cancer Revenue, Sales, Ex-factory Price
Figure 2015 Hikma Pharmaceuticals 2015 Drugs for Non-small Cell Lung Cancer Business Region Distribution
Table Hospira Information List
Table Intas Pharmaceuticals Information List
Table Karyopharm Therapeutics Information List
Table Kyowa Hakko Kirin Information List
Table Ligand Pharmaceuticals Information List
Figure Global 2016-2021 Drugs for Non-small Cell Lung Cancer Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Drugs for Non-small Cell Lung Cancer Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Drugs for Non-small Cell Lung Cancer Sales Price (USD/Unit) Forecast
Figure North America 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Drugs for Non-small Cell Lung Cancer Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Units) of Drugs for Non-small Cell Lung Cancer by Types 2016-2021
Table Global Consumption Volume (K Units) of Drugs for Non-small Cell Lung Cancer by Applications 2016-2021
Table Traders or Distributors with Contact Information of Drugs for Non-small Cell Lung Cancer by Regions
Table Part of Interviewees Record List

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *